Effects of vasopressin-mastoparan chimeric peptides on insulin release and G-protein activity

Mattias Hällbrink, Külliki Saar, Claes Göran Östenson, Ursel Soomets, Suad Efendic, John Howl, Mark Wheatley, Matjaz Zorko, Ülo Langel*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    13 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)45-51
    Number of pages7
    JournalRegulatory Peptides
    Volume82
    Issue number1-3
    DOIs
    Publication statusPublished (VoR) - 30 Jun 1999

    Funding

    This work was supported by Wenner-Gren Center, Stockholm, Sweden (stipend to M.Z.), by Structural Joint European Project S_JEP-09270-95, and by grants from the Royal Swedish Academy, Swedish Medical Research Counsel, Swedish Counsel for Engineering Sciences, Ministry of Science and Technology of Republic of Slovenia, the BBSRC and the Wellcome Trust.

    FundersFunder number
    Ministry of Science and Technology of Republic of Slovenia
    Royal Swedish Academy
    Swedish Counsel for Engineering Sciences
    Swedish Medical Research Counsel
    Wenner-Gren Center, Stockholm, SwedenS_JEP-09270-95
    Wellcome Trust
    Biotechnology and Biological Sciences Research Council

      Keywords

      • Galparan
      • GTPase
      • Insulin release
      • Mastoparan
      • PTX
      • Vasopressin

      Fingerprint

      Dive into the research topics of 'Effects of vasopressin-mastoparan chimeric peptides on insulin release and G-protein activity'. Together they form a unique fingerprint.

      Cite this